Revolution Medicines Inc.

08/07/2024 | Press release | Distributed by Public on 08/07/2024 20:19

Revolution Medicines to Provide Update on RMC-6236 Pancreatic Ductal Adenocarcinoma Clinical Program on July 15, 2024